Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
C.K. McWhorter Endows America's Cup Regatta with Prestigious McWhorter Family Trust Warrant of Excellence
-
C.K. McWhorter Endows America's Cup Regatta with Prestigious McWhorter Family Trust Warrant of Excellence
-
Genesis Capital Closes Largest Ever Rated Residential Transition Loan Securitization
-
Orion Group’s Facilities Maintenance Business Expands Exterior Footprint Through Partnership with Caliber Service Management
-
APA Corporation Announces Updates to Executive Leadership
-
Trinity Energy Launches Sensitization Campaign for Wau Power Project, Paving the Way for Economic Growth in South Sudan
-
CSE Bulletin: Suspensions - AVM.X, CANN, J, RDRS
-
LI-COR Environmental Acquires Onset®, HOBO Data Loggers
-
VIRGINIA SENATOR TIM KAINE RELEASES NEW BOOK, WALK RIDE PADDLE: A LIFE OUTSIDE, WITH HARPER HORIZON
-
CaringBridge Announces Steering Membership in Coalition to End Social Isolation and Loneliness
-
AgriCann Solutions Provides Corporate Update
-
EQB outlines progress toward a more sustainable future in 2023 Responsibility Report
-
FDA Announces Federal Court Enters Consent Decree Against Philips Respironics Following Recall of Certain Sleep Therapy Machines
-
Orion S.A. Breaks Ground on Battery Materials Plant in Texas
-
Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting
-
Arcus Biosciences Announces New Employment Inducement Grants
-
DAISO NEW STORE OPENING IN WEBSTER, TEXAS
-
US Pole Names Mercier Southeast Regional Sales Vice President
-
Applied Digital Reschedules Fiscal Third Quarter 2024 Earnings Conference Call to Thursday, April 11, 2024 at 5:00 p.m. Eastern Time
-
Vicor Corporation to Hold First Quarter Earnings Conference Call and Webcast on April 23, 2024
-
Canadian Investment Regulatory Organization Trade Resumption - PHOS
-
Scotiabank Announces Election of Directors
-
Jianzhi Education Technology Group Company Limited Reports Fiscal Year 2023 Financial Results
-
Medicenna Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation and Ongoing Dose Expansion of the Phase 1/2 ABILITY-1 Study at the 2024 Annual Meeting of the America
-
ChampionX Announces First Quarter 2024 Earnings Release Date
-
STAG INDUSTRIAL ANNOUNCES COMMON STOCK DIVIDENDS
-
HII Awarded as One of 2024’s Best Employers for Excellence in Health & Well-Being
-
Federal Realty Investment Trust Announces First Quarter 2024 Earnings Release Date and Conference Call Information
-
Ingersoll Rand Schedules First Quarter 2024 Earnings Release and Conference Call
-
Ispire Technology Inc. to Present at the Benzinga Cannabis Capital Conference on April 17, 2024
-
Paysign to Host First Quarter 2024 Earnings Call
-
Auron Unveils Preclinical Data Supporting its Lead Program and Ability of its AURIGIN™ Platform to Generate Targeted Cancer Therapies at AACR Annual Meeting
-
Harmonic Announces Conference Call to Discuss Recent Company Announcements
-
Flare Therapeutics Presents Data at AACR 2024 Annual Meeting Characterizing PPARG-Derived Immune Cell Patterns in Urothelial Cancer Patients After Anti-PD1 Therapy
-
Mettler-Toledo International Inc. to Host First Quarter 2024 Earnings Conference Call
-
Teva to Host Conference Call to Discuss First Quarter 2024 Financial Results at 8 a.m. ET on May 8, 2024
-
CENTENE SUBSIDIARY MERIDIAN IN MICHIGAN AWARDED MICHIGAN MEDICAID CONTRACTS
-
Gennao Bio Debuts Preclinical Data for First-in-Class Antibody-Drug Conjugate from Gene Monoclonal Antibody Platform (GMAB ADC)
-
Luxfer Declares Quarterly Dividend
-
New Genialis RNA Biomarker Accurately Predicts KRAS Outcomes in Lung Cancer Patients
-
Coeur Announces First Quarter 2024 Earnings Call
-
IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024
-
420 with CNW — California Officials Dispatch $12M in Grants to Fix Drug-War Harms
-
HII Awarded as One of 2024’s Best Employers for Excellence in Health & Well-Being
-
Veritex Holdings, Inc. Announces Dates of First Quarter 2024 Earnings Release and Conference Call
-
Frontier Medicines Presents New Data for First-In-Class Dual ON+OFF KRAS G12C Inhibitor FMC-376 at the AACR Annual Meeting
-
Dentsply Sirona to Host First Quarter Conference Call on May 2nd
-
Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024
-
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
-
Foghorn Therapeutics Presents New Preclinical Data on Potential First-in-Class BRM Selective Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Oncology Programs

